180 related articles for article (PubMed ID: 29293502)
1. Integration of pan-cancer transcriptomics with RPPA proteomics reveals mechanisms of epithelial-mesenchymal transition.
Koplev S; Lin K; Dohlman AB; Ma'ayan A
PLoS Comput Biol; 2018 Jan; 14(1):e1005911. PubMed ID: 29293502
[TBL] [Abstract][Full Text] [Related]
2. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
[TBL] [Abstract][Full Text] [Related]
3. Epithelial to mesenchymal transition is associated with rapamycin resistance.
Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
[TBL] [Abstract][Full Text] [Related]
4. Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib.
Suda K; Tomizawa K; Fujii M; Murakami H; Osada H; Maehara Y; Yatabe Y; Sekido Y; Mitsudomi T
J Thorac Oncol; 2011 Jul; 6(7):1152-61. PubMed ID: 21597390
[TBL] [Abstract][Full Text] [Related]
5. Effect of Trichostatin A on radiation induced epithelial-mesenchymal transition in A549 cells.
Nagaraja SS; Krishnamoorthy V; Raviraj R; Paramasivam A; Nagarajan D
Biochem Biophys Res Commun; 2017 Dec; 493(4):1534-1541. PubMed ID: 28993195
[TBL] [Abstract][Full Text] [Related]
6. HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells.
Ji M; Lee EJ; Kim KB; Kim Y; Sung R; Lee SJ; Kim DS; Park SM
Oncol Rep; 2015 May; 33(5):2299-308. PubMed ID: 25813246
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
Shah P; Gau Y; Sabnis G
Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
[TBL] [Abstract][Full Text] [Related]
8. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.
Nam EH; Lee Y; Park YK; Lee JW; Kim S
Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038
[TBL] [Abstract][Full Text] [Related]
9. The effect of Pokemon on bladder cancer epithelial-mesenchymal transition.
Guo C; Zhu K; Sun W; Yang B; Gu W; Luo J; Peng B; Zheng J
Biochem Biophys Res Commun; 2014 Jan; 443(4):1226-31. PubMed ID: 24393848
[TBL] [Abstract][Full Text] [Related]
10. Trichostatin A, a histone deacetylase inhibitor, reverses epithelial-mesenchymal transition in colorectal cancer SW480 and prostate cancer PC3 cells.
Wang X; Xu J; Wang H; Wu L; Yuan W; Du J; Cai S
Biochem Biophys Res Commun; 2015 Jan; 456(1):320-6. PubMed ID: 25434997
[TBL] [Abstract][Full Text] [Related]
11. A Transcriptional Program for Detecting TGFβ-Induced EMT in Cancer.
Foroutan M; Cursons J; Hediyeh-Zadeh S; Thompson EW; Davis MJ
Mol Cancer Res; 2017 May; 15(5):619-631. PubMed ID: 28119430
[TBL] [Abstract][Full Text] [Related]
12. SAMNet: a network-based approach to integrate multi-dimensional high throughput datasets.
Gosline SJ; Spencer SJ; Ursu O; Fraenkel E
Integr Biol (Camb); 2012 Nov; 4(11):1415-27. PubMed ID: 23060147
[TBL] [Abstract][Full Text] [Related]
13. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
[TBL] [Abstract][Full Text] [Related]
14. Chidamide alleviates TGF-β-induced epithelial-mesenchymal transition in lung cancer cell lines.
Lin SH; Wang BY; Lin CH; Chien PJ; Wu YF; Ko JL; Chen JJ
Mol Biol Rep; 2016 Jul; 43(7):687-95. PubMed ID: 27188428
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer quantitation of epithelial-mesenchymal transition dynamics using parallel reaction monitoring-based targeted proteomics approach.
Jain AP; Sambath J; Sathe G; George IA; Pandey A; Thompson EW; Kumar P
J Transl Med; 2022 Feb; 20(1):84. PubMed ID: 35148768
[TBL] [Abstract][Full Text] [Related]
16. Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer.
Zhou J; Wang J; Zeng Y; Zhang X; Hu Q; Zheng J; Chen B; Xie B; Zhang WM
Oncotarget; 2015 Dec; 6(42):44332-45. PubMed ID: 26554308
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events.
Matos ML; Lapyckyj L; Rosso M; Besso MJ; Mencucci MV; Briggiler CI; Giustina S; Furlong LI; Vazquez-Levin MH
J Cell Physiol; 2017 Jun; 232(6):1368-1386. PubMed ID: 27682981
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
[TBL] [Abstract][Full Text] [Related]
19. Expression of epithelial-mesenchymal transition-related genes increases with copy number in multiple cancer types.
Zhao M; Liu Y; Qu H
Oncotarget; 2016 Apr; 7(17):24688-99. PubMed ID: 27029057
[TBL] [Abstract][Full Text] [Related]
20. Integrative proteomic analysis reveals reprograming tumor necrosis factor signaling in epithelial mesenchymal transition.
Zhao Y; Tian B; Sadygov RG; Zhang Y; Brasier AR
J Proteomics; 2016 Oct; 148():126-38. PubMed ID: 27461979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
